Log In
Print
BCIQ
Print
Print this Print this
 

OrbeShield (SGX202)

  Manage Alerts
Collapse Summary General Information
Company Soligenix Inc.
DescriptionOral formulation of beclomethasone dipropionate (BDP) consisting of one tablet intended to release BDP in the proximal portions of the GI tract and another to release BDP in the distal portions.
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationPoisoning
Indication DetailsPrevent death following a potentially lethal dose of total body irradiation (TBI) during or after a radiation disaster; Treat gastrointestinal acute radiation syndrome (ARS); Treat radiation injury
Regulatory Designation

U.S. - Fast Track (Treat gastrointestinal acute radiation syndrome (ARS));
U.S. - Orphan Drug (Prevent death following a potentially lethal dose of total body irradiation (TBI) during or after a radiation disaster)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today